Sentence examples for currently low levels of from inspiring English sources

Currently low levels of HDL-C are considered an independent risk factor for the development of cardiovascular disease [ 9].

This historic experience suggests that, though ambitious, the benchmark can be achieved even in countries with currently low levels of demand satisfied with modern methods.

The currently low levels of production will not have a substantial impact on the health care needs of the country and considerable scaling up is required to meet the minimum target of 1,350 clinical associates, equivalent to five per district hospital (9), let alone the 16 20 clinical associates per hospital that some key informants estimated are actually required.

Nurse-supported shared care services for patients living with hepatitis C have been implemented in some regional areas of Western Australia to provide access to local treatment and care services for patients and to improve currently low levels of treatment uptake.

For example, a 2004 paper by Joshua Gallin, a Fed economist, concluded: "Indeed, one might be tempted to cite the currently low level of the rent-price ratio as a sign that we are in a house-price 'bubble.'" But the paper did not endorse this view, saying that "several important caveats argue against such a strong conclusion and in favor of further research".

During this process, natural selection favors predators that preferentially attack the local prey species with the currently lowest levels of defense.

Still, conservatives are fighting to keep the estate tax at its currently low level, and Sen. Orrin Hatch (R-Utah) is pushing to get rid of it entirely.

Whereas the left peak represents the cells that currently express low levels of Nanog, the right peak corresponds to the cells with high Nanog concentrations.

The lack of antibody levels in the first year of life may be compensated by maternal antibodies, but women of childbearing age also currently have low levels of MenC-specific IgG and SBA, leaving the newborns vulnerable until the first vaccination at 14 months.

These represent levels of cycling which we believe are realistic to achieve in countries such as the UK, which currently have low levels of utility cycling.

Pharmaceutically relevant virus-like particles (VLPs) can potentially be manufactured cheaply and efficiently through in vitro assembly of viral structural protein in cell-free reactors, but a bottleneck for this processing route is the currently low-level expression of soluble viral protein in efficient cell factories such as Escherichia coli (E. coli).